New thiazolyl-isoxazole derivatives as potential anti-infective agents: design, synthesis, and antimicrobial efficacy.

Antimicrobial resistance threatens the efficacious prevention and treatment of infectious diseases caused by microorganisms. To combat microbial infections, the need for new drug candidates is essential. In this context, the design, synthesis, antimicrobial screening, and study of a new series of 5-aryl-3-(2-arylthiazol-4-yl)isoxazole () have been reported.